Drug
4 mg nicotine gum
4 mg nicotine gum is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_4
1
33%
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(3)
Detailed Status
Completed3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 41 (33.3%)
N/A2 (66.7%)
Trials by Status
completed3100%
Recent Activity
0 active trials
Showing 3 of 3
completednot_applicable
Single-dose Nicotine Pharmacokinetics With Four Oral Nicotine Replacement Products
NCT01234896
completednot_applicable
Single-dose Nicotine Pharmacokinetics With Three Oral Nicotine Replacement Products. A Study in Healthy Smokers.
NCT01234792
completedphase_4
A Pilot Drug Trial That Evaluates the Whitening Potential of Nicotine Gum
NCT00174499
Clinical Trials (3)
Showing 3 of 3 trials
NCT01234896Not Applicable
Single-dose Nicotine Pharmacokinetics With Four Oral Nicotine Replacement Products
NCT01234792Not Applicable
Single-dose Nicotine Pharmacokinetics With Three Oral Nicotine Replacement Products. A Study in Healthy Smokers.
NCT00174499Phase 4
A Pilot Drug Trial That Evaluates the Whitening Potential of Nicotine Gum
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3